Sergey Yu. Ivanov

Sergey Yu. Ivanov

Auto-generated profile, based on publicly available information

Sergey Yu. Ivanov

Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
AVAlexey V. Volkov
Alexey V. Volkov
AMAlexander A. Muraev
Alexander A. Muraev
IZIrina I. Zharkova
Irina I. Zharkova
VVVera V. Voinova
Vera V. Voinova
EAElizaveta A. Akoulina
Elizaveta A. Akoulina
ABAnton Bonartsev
Anton Bonartsev

7 March 2022 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
STS. Tereshchuk
S. Tereshchuk
SIS. Yu Ivanov
S. Yu Ivanov
VSV. Sukharev
V. Sukharev

1 January 2017 in Stomatologiya
Verified
Journal Article
Open access
PDF file
AMAleksandr Muraev
Aleksandr Muraev
SIS. Yu. Ivanov
S. Yu. Ivanov
SIS. G. Ivashkevich
S. G. Ivashkevich
VGV. N. Gorshenev
V. N. Gorshenev
ATA. T. Teleshev
A. T. Teleshev
VDV. K. Dubrovin
V. K. Dubrovin
Medical article медицинская статья

1 December 2016 in Sovremennye tehnologii v medicine
Verified
Journal Article
Open access
AMAleksandr Muraev
Aleksandr Muraev
ABAnton Bonartsev
Anton Bonartsev
YGYu.V. Gazhva
Yu.V. Gazhva
VRV.M. Riabova
V.M. Riabova
AVAlexey Volkov
Alexey Volkov
SIS.Yu. Ivanov
S.Yu. Ivanov

17 November 2021 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
IAI. I. Antonov
I. I. Antonov
VMV. P. Mudrov
V. P. Mudrov
VNV. N. Nelyubin
V. N. Nelyubin
AMAleksandr Muraev
Aleksandr Muraev
SIS. Yu. Ivanov
S. Yu. Ivanov
Impairment of immunological reactivity in inflammatory periodontal diseases is well proven. To perform immunomodulatory treatment in domestic dental practice, various medications are used, including natural, chemically modified, recombinant, genetically engineered and synthetic substances, which differ in their effects upon innate and adaptive immune systems. Complex preparations of natural cytokines as well as genetically engineered preparations of IL-1, IL-2, growth factors, IFNα, IFNβ, IFNγ are applied in clinical settings. Clinical implementation of interferon and interferon inducers in combined therapy of generalized periodontitis is shown to increase resistance to viral components of the oral microbiota. Growth factors (platelet growth factor, fibroblast growth factor, endothelial growth factor, etc.) are successfully used for tissue regeneration in periodontics and maxillofacial surgery. Experimental studies have shown that local administration of toll-like receptor-9 and CD40 ligand may reduce periodontal ligature inflammation and bone loss in mice by inducing B-cell proliferation and increasing IL-10 mRNA expression. Promising results in development of new biologically active drugs are obtained with nanotechnology approaches, i.e., production of composite materials of metal nanoparticles with polymers, growth factors, and local application of these products. General limitations of all these growth factors include extremely short periods of biological activity, and adjusted duration of local effective concentrations. Therefore, it is important to develop a drug delivery system using appropriate scaffolding elements thus allowing local effects of the drug for a certain period of time. In experimental models, alginate hydrogels performed well upon local delivery of granulocyte-macrophage colony-stimulating factor and stromal lymphopoietin of the thymus. A new immunomodulatory strategy for alveolar bone regeneration targets macrophages. A biologically functionalized injectable microsphere of heparin-modified gelatin nanofibers that mimic the architecture of the natural bone extracellular matrix, and provide an osteoconductive microenvironment for bone cells includes IL-4, which has heparin-binding domains. These medications represent a component of a comprehensive treatment schedule, and should be evaluated for immune status before and after therapy. Thus, recent advances in studies of innate and acquired immune responses in inflammatory diseases and, in particular, in periodontal disorders, allows us to develop new approaches and methods of treatment in order to improve efficiency of complex therapy in the inflammatory periodontal diseases.

1 June 2017 in Sovremennye tehnologii v medicine
Verified
Journal Article
Open access
AMAleksandr Muraev
Aleksandr Muraev
YGY.V. Gazhva
Y.V. Gazhva
SIS.G. Ivashkevich
S.G. Ivashkevich
VRV.M. Riabova
V.M. Riabova
NKN.L. Korotkova
N.L. Korotkova
SIS.Y. Ivanov
S.Y. Ivanov